Browsing by Author "Poveda, Andres"
Now showing items 1-3 of 3
-
A phase I dose-finding, pharmacokinetics and genotyping study of olaparib and lurbinectedin in patients with advanced solid tumors
Poveda, Andres; Oaknin Benzaquen, Ana Mazaltob; Romero, Ignacio; Guerrero‑Zotano, Angel; Fariñas Madrid, Lorena; Rodriguez‑Freixinos, Victor (Nature Research, 2021-02-24) -
Olaparib maintenance monotherapy in platinum-sensitive relapsed ovarian cancer patients without a germline BRCA1/BRCA2 mutation: OPINION primary analysis
Poveda, Andres; Lheureux, S.; Cibula, David; Lindemann, Kristina; Weberpals, J.; Oaknin Benzaquen, Ana Mazaltob; Colombo, Nicoletta (Elsevier, 2022-03) -
Phase 2 Trial (POLA Study) of Lurbinectedin plus Olaparib in Patients with Advanced Solid Tumors: Results of Efficacy, Tolerability, and the Translational Study
Poveda, Andres; Oaknin Benzaquen, Ana Mazaltob; Redondo Sanchez, Andres; Rubio, Maria Jesus; Guerra, Eva; Fariñas Madrid, Lorena; Rodriguez Freixinos, Victor; López-Reig, Raquel (MDPI, 2022-02-12)